Jupiter Life Line Hospitals Reports Strong FY26 Performance

Jupiter Life Line Hospitals announced robust financial results for the fiscal year ending March 31, 2026. Total income reached INR 1,499.8 crores, a significant 15.2% rise from the previous year. The company also reported Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of INR 343.3 crores, with a healthy margin of 22.9%. Profit After Tax (PAT) stood at INR 194.2 crores.

Fourth Quarter Highlights

In the fourth quarter ending March 31, 2026, Jupiter Life Line Hospitals saw its revenue grow by 15.1% to INR 387.8 crores. Quarterly EBITDA was INR 89.2 crores, maintaining a strong margin of 23%, and PAT for the quarter was INR 50.2 crores.

Expansion Progress

The company highlighted its ongoing expansion strategy, with key projects like the Dombivli hospital opening ahead of schedule in February 2026. This 500-bed facility was constructed within 24 months without cost overruns. Other expansion initiatives in Pune South and Mira Road are progressing as planned. A major focus remains on the development of a quaternary care hospital in BKC, Mumbai.

Strategic Outlook

Jupiter Life Line Hospitals aims to add approximately 1,700 beds, increasing its total capacity to nearly 3,000 beds. The expansion will be financed through a combination of internal funds and debt, with a strategic goal to keep total debt below three times EBITDA. The company is prioritizing domestic patient demand over international medical tourism.

Potential Risks

Management has noted potential challenges, including the impact of inflation on operating costs, the effect of a depreciating rupee on capital expenditure, and possible disruptions in global supply chains affecting consumable prices. These factors are being closely monitored to mitigate their effect on financial returns.

Key Metrics

For FY26, total income was INR 1,499.8 crores (up 15.2% YoY), and EBITDA was INR 343.3 crores (up 14.4% YoY). Q4 FY26 revenue reached INR 387.8 crores (up 15.1% YoY). The Average Revenue Per Operating Bed (ARPOB) increased by 11.7% year-on-year to INR 67,700. Bed occupancy across three existing hospitals was 61.2%.

Future Focus

Investors will be watching the ramp-up of the new Dombivli hospital, with specific attention on its path to profitability by Year 2 and EBITDA breakeven by Q4 FY28. Progress on regulatory approvals for Thane and Mira Road projects, along with the BKC hospital's land payment and construction, will also be key indicators.